Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Pellini, Bruna; W. Madison, Russell; Childress, Merrida; T. Miller, Shoshana; Gjoerup, Ole; Cheng, Jason; S.P. Huang, Richard; Krainock, Michael; Gupta, Pratyush; Zou, Wei; S. Shames, David; Moshkevich, Solomon; Ballinger, M.; C. Liu, Minetta; Young, Amanda; K. Srivastava, Minu; R. Oxnard, Geoffrey; A. Socinski, Mark

doi:10.1158/1078-0432.ccr-23-1578

Public

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Published in Clinical Cancer Research • Sep 13, 2023

Authors:

Bruna Pellini

Russell W. Madison

Merrida Childress

Abstract

PURPOSE: Chemoimmunotherapy (chemoIO) is a prevalent first-line treatment for advanced driver-negative non-small cell lung cancer (NSCLC), with maintenance therapy given after induction. However, there is significant clinical variability in the duration, dosing, and timing of maintenance therapy aft...

Subject

Medicine

Internal medicine

Carboplatin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!